[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Kidney Cancer Drug Market Research Report Forecast 2017-2021

May 2017 | 119 pages | ID: UF8D58362B1EN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Kidney Cancer Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Kidney Cancer Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Kidney Cancer Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics

United States Kidney Cancer Drug Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Kidney Cancer Drug Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 KIDNEY CANCER DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Kidney Cancer Drug
1.2 Kidney Cancer Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of Kidney Cancer Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Kidney Cancer Drug Market Segmentation by Application
  1.3.1 Kidney Cancer Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Kidney Cancer Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON KIDNEY CANCER DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES KIDNEY CANCER DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States Kidney Cancer Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States Kidney Cancer Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Kidney Cancer Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Kidney Cancer Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Kidney Cancer Drug Market Competitive Situation and Trends
  3.5.1 Kidney Cancer Drug Market Concentration Rate
  3.5.2 Kidney Cancer Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES KIDNEY CANCER DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Kidney Cancer Drug Production and Market Share by Type (2012-2017)
4.2 United States Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Kidney Cancer Drug Price by Type (2012-2017)
4.4 United States Kidney Cancer Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES KIDNEY CANCER DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States Kidney Cancer Drug Consumption and Market Share by Application (2012-2017)
5.2 United States Kidney Cancer Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES KIDNEY CANCER DRUG MANUFACTURERS ANALYSIS

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 F. Hoffmann-La Roche
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 GlaxoSmithKline
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Novartis
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Abbott Laboratories
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Active Biotech
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Amgen
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Argos Therapeutics
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 KIDNEY CANCER DRUG MANUFACTURING COST ANALYSIS

7.1 Kidney Cancer Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Kidney Cancer Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Kidney Cancer Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES KIDNEY CANCER DRUG MARKET FORECAST (2017-2021)

11.1 United States Kidney Cancer Drug Production, Revenue Forecast (2017-2021)
11.2 United States Kidney Cancer Drug Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Kidney Cancer Drug Production Forecast by Type (2017-2021)
11.4 United States Kidney Cancer Drug Consumption Forecast by Application (2017-2021)
11.5 Kidney Cancer Drug Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Kidney Cancer Drug
Table Classification of Kidney Cancer Drug
Figure United States Sales Market Share of Kidney Cancer Drug by Type in 2015
Table Application of Kidney Cancer Drug
Figure United States Sales Market Share of Kidney Cancer Drug by Application in 2015
Figure United States Kidney Cancer Drug Sales and Growth Rate (2011-2021)
Figure United States Kidney Cancer Drug Revenue and Growth Rate (2011-2021)
Table United States Kidney Cancer Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Kidney Cancer Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Kidney Cancer Drug Sales Share by Manufacturers
Figure 2016 Kidney Cancer Drug Sales Share by Manufacturers
Table United States Kidney Cancer Drug Revenue by Manufacturers (2015 and 2016)
Table United States Kidney Cancer Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Kidney Cancer Drug Revenue Share by Manufacturers
Table 2016 United States Kidney Cancer Drug Revenue Share by Manufacturers
Table United States Market Kidney Cancer Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Kidney Cancer Drug Average Price of Key Manufacturers in 2015
Figure Kidney Cancer Drug Market Share of Top 3 Manufacturers
Figure Kidney Cancer Drug Market Share of Top 5 Manufacturers
Table United States Kidney Cancer Drug Sales by Type (2012-2017)
Table United States Kidney Cancer Drug Sales Share by Type (2012-2017)
Figure United States Kidney Cancer Drug Sales Market Share by Type in 2015
Table United States Kidney Cancer Drug Revenue and Market Share by Type (2012-2017)
Table United States Kidney Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Kidney Cancer Drug by Type (2012-2017)
Table United States Kidney Cancer Drug Price by Type (2012-2017)
Figure United States Kidney Cancer Drug Sales Growth Rate by Type (2012-2017)
Table United States Kidney Cancer Drug Sales by Application (2012-2017)
Table United States Kidney Cancer Drug Sales Market Share by Application (2012-2017)
Figure United States Kidney Cancer Drug Sales Market Share by Application in 2015
Table United States Kidney Cancer Drug Sales Growth Rate by Application (2012-2017)
Figure United States Kidney Cancer Drug Sales Growth Rate by Application (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Kidney Cancer Drug Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffmann-La Roche Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Kidney Cancer Drug Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Kidney Cancer Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Kidney Cancer Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Kidney Cancer Drug Market Share (2012-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Kidney Cancer Drug Market Share (2012-2017)
Table Active Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Active Biotech Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Active Biotech Kidney Cancer Drug Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Kidney Cancer Drug Market Share (2012-2017)
Table Argos Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Argos Therapeutics Kidney Cancer Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Argos Therapeutics Kidney Cancer Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Kidney Cancer Drug
Figure Manufacturing Process Analysis of Kidney Cancer Drug
Figure Kidney Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Kidney Cancer Drug Major Manufacturers in 2015
Table Major Buyers of Kidney Cancer Drug
Table Distributors/Traders List
Figure United States Kidney Cancer Drug Production and Growth Rate Forecast (2017-2021)
Figure United States Kidney Cancer Drug Revenue and Growth Rate Forecast (2017-2021)
Table United States Kidney Cancer Drug Production Forecast by Type (2017-2021)
Table United States Kidney Cancer Drug Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Novartis
Pfizer
Abbott Laboratories
Active Biotech
Amgen
Argos Therapeutics
ArQule
AVEO Pharmaceuticals
Bionomics
Bristol-Myers Squibb
Cerulean Pharma
Exelixis
Genentech
immatics biotechnologies
Immunicum
Ono Pharmaceutical
Onyx Therapeutics
Oxford BioMedica
Prometheus Laboratories
Seattle Genetics
Taiwan Liposome
TRACON Pharmaceuticals
Wilex


More Publications